BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1827755)

  • 1. Expression of aberrant O-glycans attached to leukosialin in differentiation-deficient HL-60 cells.
    Saitoh O; Gallagher RE; Fukuda M
    Cancer Res; 1991 Jun; 51(11):2854-62. PubMed ID: 1827755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans.
    Maemura K; Fukuda M
    J Biol Chem; 1992 Dec; 267(34):24379-86. PubMed ID: 1447188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-glycosylation of leukosialin in K562 cells. Evidence for initiation and elongation in early Golgi compartments.
    Piller V; Piller F; Klier FG; Fukuda M
    Eur J Biochem; 1989 Jul; 183(1):123-35. PubMed ID: 2526734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin.
    Saitoh O; Piller F; Fox RI; Fukuda M
    Blood; 1991 Apr; 77(7):1491-9. PubMed ID: 1826222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase.
    Bierhuizen MF; Maemura K; Fukuda M
    J Biol Chem; 1994 Feb; 269(6):4473-9. PubMed ID: 8308016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of truncated O-glycans in the T cell line Jurkat. Localization of O-glycan initiation.
    Piller V; Piller F; Fukuda M
    J Biol Chem; 1990 Jun; 265(16):9264-71. PubMed ID: 2140570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural variations of O-linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T-lymphoid cell lines.
    Carlsson SR; Sasaki H; Fukuda M
    J Biol Chem; 1986 Sep; 261(27):12787-95. PubMed ID: 2943741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukosialin, a major sialoglycoprotein defining leucocyte differentiation.
    Fukuda M
    Ciba Found Symp; 1989; 145():257-68; discussion 268-76. PubMed ID: 2529107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen.
    Bierhuizen MF; Fukuda M
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9326-330. PubMed ID: 1329093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
    Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
    Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy.
    Fukuda M
    Glycobiology; 1991 Sep; 1(4):347-56. PubMed ID: 1840294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of synthetic sialic acid analogues to N- and O-linked glycoprotein glycans using four different mammalian sialyltransferases.
    Gross HJ; Rose U; Krause JM; Paulson JC; Schmid K; Feeney RE; Brossmer R
    Biochemistry; 1989 Sep; 28(18):7386-92. PubMed ID: 2510824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis.
    Piller F; Piller V; Fox RI; Fukuda M
    J Biol Chem; 1988 Oct; 263(29):15146-50. PubMed ID: 2971663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.
    Brockhausen I; Kuhns W; Schachter H; Matta KL; Sutherland DR; Baker MA
    Cancer Res; 1991 Feb; 51(4):1257-63. PubMed ID: 1997166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
    Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of O-glycan biosynthesis in human colon cancer tissues.
    Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
    Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells.
    Wilkins PP; McEver RP; Cummings RD
    J Biol Chem; 1996 Aug; 271(31):18732-42. PubMed ID: 8702529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface membrane glycoproteins of wild-type and differentiation-inducer-resistant HL-60 cells.
    Felsted RL; Gupta SK; Glover CJ; Gallagher RE
    Blood; 1985 Sep; 66(3):606-13. PubMed ID: 4027382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyposialylation of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Giangiulio DA; Chang CS; Glover CJ; Felsted RL
    Blood; 1986 Dec; 68(6):1402-6. PubMed ID: 3779103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60.
    Grillier I; Umiel T; Elstner E; Collins SJ; Koeffler HP
    Leukemia; 1997 Mar; 11(3):393-400. PubMed ID: 9067579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.